NCT01484730

Brief Summary

The purpose of this research is to evaluate and validate the performance of non-invasive imaging modalities for assessment of skin. A pressure cuff occlusion will be used to stimulate blood flow dynamic that these instruments are designed to sense. The researcher currently plan to assess only basic feasibility of the imaging instruments.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
27mo left

Started Nov 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Nov 2011Aug 2028

Study Start

First participant enrolled

November 1, 2011

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

November 29, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 2, 2011

Completed
14.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2028

Last Updated

December 10, 2025

Status Verified

December 1, 2025

Enrollment Period

14.8 years

First QC Date

November 29, 2011

Last Update Submit

December 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Skin blood flow

    The key factor of interest is measuring the changes in the fluorescence signal of the epidermal cells during the arm occlusion, which will provide information about changes in cellular metabolism during cellular oxygen deprivation. Time series of optical sections (two-dimensional x-y images parallel to the skin surface of about 250x250 µm2) at the same depth will be obtained before, during and after the arm occlusion. The images will be based on two-photon excitation of endogenous fluorophores (NADH). To quantify the fluorescence signal, which will provide information about changes of cellular metabolism, we will use the integrated brightness of each image (same rectangular area for all images) as a measure of the signal. The integrated brightness is defined as the sum of pixels weighted over the brightness values (or gray values) of the pixel. A statistical plan is not appropriate at this stage of the pilot study.

    4 weeks

Study Arms (1)

Vascular Occlusion

Multi-Spectral and Laser Speckle Imaging

Device: Multi-Spectral and Laser Speckle Imaging

Interventions

Changes in skin tissue and blood flow.

Vascular Occlusion

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study population will be selected from University of California Irvine, student and staff member.

You may qualify if:

  • Male and female adult 18 years and older

You may not qualify if:

  • Younger than 18 years of age
  • Pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beckman Laser Institute and Medical Clinic

Irvine, California, 92612, United States

RECRUITING

MeSH Terms

Interventions

Laser Speckle Contrast Imaging

Intervention Hierarchy (Ancestors)

Optical ImagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Study Officials

  • Anthony Durkin, PhD

    University of California, Irvine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gordon Kennedy, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Researcher, BME & Surgery, Director, Laboratory for Functional Imaging Lab

Study Record Dates

First Submitted

November 29, 2011

First Posted

December 2, 2011

Study Start

November 1, 2011

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

August 1, 2028

Last Updated

December 10, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations